Regnum Corp. (RGMP)

USD 0.0

(0.0%)

Operating Expenses Summary of Regnum Corp.

  • Regnum Corp.'s latest annual operating expenses in 2022 was 735.83 Thousand USD , up 99.75% from previous year.
  • Regnum Corp.'s latest quarterly operating expenses in 2023 Q3 was - USD , down 0.0% from previous quarter.
  • Regnum Corp. reported a annual operating expenses of 368.37 Thousand USD in annual operating expenses 2021, up 196.01% from previous year.
  • Regnum Corp. reported a annual operating expenses of 124.44 Thousand USD in annual operating expenses 2020, up 197.15% from previous year.
  • Regnum Corp. reported a quarterly operating expenses of - USD for 2023 Q2, down -100.0% from previous quarter.
  • Regnum Corp. reported a quarterly operating expenses of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Regnum Corp. (2022 - 2016)

Historical Annual Operating Expenses of Regnum Corp. (2022 - 2016)

Year Operating Expenses Operating Expenses Growth
2022 735.83 Thousand USD 99.75%
2021 368.37 Thousand USD 196.01%
2020 124.44 Thousand USD 197.15%
2019 41.88 Thousand USD 133.25%
2018 17.95 Thousand USD 13.28%
2017 15.85 Thousand USD 1821.21%
2016 825.00 USD 0.0%

Peer Operating Expenses Comparison of Regnum Corp.

Name Operating Expenses Operating Expenses Difference
Burzynski Research Institute, Inc. 1.33 Million USD 44.899%
Arch Therapeutics, Inc. 5.04 Million USD 85.406%
Evofem Biosciences, Inc. 29.55 Million USD 97.51%
Nascent Biotech, Inc. 2.22 Million USD 67.001%
Rebus Holdings, Inc. 664 Thousand USD -10.819%
Santhera Pharmaceuticals Holding AG 37.25 Million USD 98.025%
Qrons Inc. 643.67 Thousand USD -14.317%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. 389.56 Thousand USD -88.886%
Northwest Biotherapeutics, Inc. 57.44 Million USD 98.719%
ProtoKinetix, Incorporated 415.47 Thousand USD -77.105%
Skye Bioscience, Inc. 13.54 Million USD 94.569%
Eiger BioPharmaceuticals, Inc. 86.78 Million USD 99.152%
Nanobac Pharmaceuticals, Incorporated 4.91 Million USD 85.038%
Institute of Biomedical Research Corp. 261.72 Thousand USD -181.147%
SQZ Biotechnologies Company 85.61 Million USD 99.141%
Intellipharmaceutics International Inc. 2.91 Million USD 74.768%
Propanc Biopharma, Inc. 1.5 Million USD 51.006%
Mesoblast Limited 5.9 Million USD 87.532%
Marizyme, Inc. 19.23 Million USD 96.175%
Genus plc 147.7 Million USD 99.502%
VioQuest Pharmaceuticals, Inc. 8.77 Million USD 91.618%
Pharming Group N.V. 225.49 Million USD 99.674%
Therapeutic Solutions International, Inc. 2.04 Million USD 64.083%
CNBX Pharmaceuticals Inc. 1.34 Million USD 45.15%
Nymox Pharmaceutical Corporation 8.33 Million USD 91.176%
ContraFect Corporation 56.88 Million USD 98.707%
PsyBio Therapeutics Corp. 4.4 Million USD 83.309%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.47 Million USD 50.239%
IMV Inc. 37.7 Million USD 98.049%
AXIM Biotechnologies, Inc. 2.79 Million USD 73.629%
MultiCell Technologies, Inc. 567.42 USD -129580.836%
ONE Bio Corp. 6.44 Million USD 88.581%
Accustem Sciences Inc. 3.74 Million USD 80.359%
RVL Pharmaceuticals plc 85.94 Million USD 99.144%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 531.96 Thousand USD -38.325%
Q BioMed Inc. 3.43 Million USD 78.588%
Emmaus Life Sciences, Inc. 24.71 Million USD 97.023%
Mosaic ImmunoEngineering Inc. 2.62 Million USD 71.995%
Biomind Labs Inc. 994.18 Thousand USD 25.986%
American Oriental Bioengineering, Inc. 99.33 Million USD 99.259%
Provectus Biopharmaceuticals, Inc. 1.75 Million USD 58.184%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 6.71 Million USD 89.047%
GlobeStar Therapeutics Corporation 1.86 Million USD 60.532%
THC Farmaceuticals, Inc. -25 Thousand USD 3043.34%
Acro Biomedical Co., Ltd. 16.01 Million USD 95.404%
Curative Biotechnology, Inc. 1.83 Million USD 59.902%
GB Sciences, Inc. 1.42 Million USD 48.199%
Alpha Cognition Inc. 9.7 Million USD 92.418%
HST Global, Inc. 140.9 Thousand USD -422.213%
CSL Limited 3.44 Billion USD 99.979%
Wesana Health Holdings Inc. 1.12 Million USD 34.587%
Halberd Corporation 74.84 Thousand USD -883.185%
Enzolytics Inc. 2.17 Million USD 66.238%
Agentix Corp. 1.37 Million USD 46.358%
Resverlogix Corp. 12.71 Million USD 94.211%
Nuo Therapeutics, Inc. 3.65 Million USD 79.844%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.53 Billion USD 99.952%
Enzon Pharmaceuticals, Inc. 1.04 Million USD 29.518%
Endonovo Therapeutics, Inc. 2.4 Million USD 69.403%
RespireRx Pharmaceuticals Inc. 1.57 Million USD 53.409%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. 3.4 Million USD 78.389%
AVAX Technologies, Inc. 7.31 Million USD 89.934%
Zenith Capital Corp. 8.94 Million USD 91.772%
Genscript Biotech Corporation 825.34 Million USD 99.911%
Ember Therapeutics, Inc. 17.42 Thousand USD -4123.839%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 2.45 Million USD 70.031%
WPD Pharmaceuticals Inc. 171.5 Thousand USD -329.036%
Cotinga Pharmaceuticals Inc. 1.92 Million USD 61.693%
Kadimastem Ltd 2.41 Million USD 69.469%
Helix BioMedix, Inc. 1.97 Million USD 62.686%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 10.86 Million USD 93.229%
BioStem Technologies, Inc. 22.97 Million USD 96.797%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 181.48 Thousand USD -305.452%
LadRx Corporation 3.81 Million USD 80.696%
Cell Source, Inc. 4.32 Million USD 82.988%
Regen BioPharma, Inc. 923.51 Thousand USD 20.322%
Regen BioPharma, Inc. 923.51 Thousand USD 20.322%
NovAccess Global Inc. 2.46 Million USD 70.17%
Affymax, Inc. 39.38 Million USD 98.132%
Itoco Inc. 919.14 Thousand USD 19.943%
Rasna Therapeutics, Inc. 4.23 Million USD 82.639%
Pathfinder Cell Therapy, Inc. 1.11 Million USD 34.242%
Mobile Lads Corp. 554.54 Thousand USD -32.691%
CytoDyn Inc. 18.05 Million USD 95.925%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. 25.16 Thousand USD -2823.577%
NanoSphere Health Sciences Inc. 220.07 Thousand USD -234.352%
Alseres Pharmaceuticals, Inc. 1.41 Million USD 48.173%
SYBLEU INC 160.87 Thousand USD -357.393%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 1.81 Million USD 59.488%
International Stem Cell Corporation 5.27 Million USD 86.04%
Bioxytran, Inc. 3.82 Million USD 80.738%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. 52.64 Thousand USD -1297.81%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. 20.34 Thousand USD -3517.141%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 36.26 Million USD 97.971%
Adhera Therapeutics, Inc. 1.61 Million USD 54.522%
RenovaCare, Inc. - USD -Infinity%
Innovation Pharmaceuticals Inc. 3.11 Million USD 76.347%
Neutra Corp. 243.82 Thousand USD -201.793%
Windtree Therapeutics, Inc. 17.45 Million USD 95.785%
PureTech Health plc 144.59 Million USD 99.491%
Coeptis Therapeutics, Inc. 20.48 Million USD 96.409%
IXICO plc 4.7 Million USD 84.367%
IntelGenx Technologies Corp. 8.79 Million USD 91.635%
Gelesis Holdings, Inc. 117.74 Million USD 99.375%
CSL Limited 3.89 Billion USD 99.981%
Cellectis S.A. 97.32 Million USD 99.244%